Dogwood Therapeutics (DWTX) Earnings Date, Estimates & Call Transcripts $4.95 +0.01 (+0.20%) Closing price 03:57 PM EasternExtended Trading$4.96 +0.01 (+0.30%) As of 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Dogwood Therapeutics Earnings Summary Dogwood Therapeutics released Q2 2025 earnings on August 13, 2025, reporting an EPS of -$1.99, which missed analysts' consensus estimates of -$1.26 by $0.73. With a trailing EPS of -$18.78, Dogwood Therapeutics' earnings are expected to grow next year, from ($6.43) to ($4.57) per share. Upcoming Q3 Earnings DateNov. 6Before Market OpensEstimatedConsensus EPS (Aug. 13) -$1.26 Actual EPS (Aug. 13) -$1.99 Missed By -$0.73 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)DWTX Upcoming EarningsDogwood Therapeutics' next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules. Powered by Get Dogwood Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dogwood Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataDWTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Dogwood Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.05-$0.48-$0.77Q2 20252-$2.00-$0.51-$1.26Q3 20251-$2.00-$2.00-$2.00Q4 20251-$2.00-$2.00-$2.00 Dogwood Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/6/2025(Estimated)--------8/13/2025Q2 2025-$1.26-$1.99 -$0.73-$1.99--5/8/2025Q1 2025-$0.77-$4.21 -$3.44-$8.45--3/31/2025Q4 2024-$1.49-$6.29 -$4.80-$6.29--11/7/2024Q3 2024-$1.33-$2.05 -$0.72-$2.05--8/8/2024Q2 2024-$1.75-$1.25+$0.50-$1.25--5/9/2024Q1 2024-$2.00-$1.75+$0.25-$1.75--2/29/2024Q4 2023-$2.25-$1.50+$0.75-$1.50--11/13/2023Q3 2023-$2.50-$1.50+$1.00-$1.50-- Dogwood Therapeutics Earnings - Frequently Asked Questions When is Dogwood Therapeutics' earnings date? Dogwood Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based off last year's report dates. Learn more on DWTX's earnings history. Did Dogwood Therapeutics beat their earnings estimates last quarter? In the previous quarter, Dogwood Therapeutics (NASDAQ:DWTX) missed the analysts' consensus estimate of ($1.26) by $0.73 with a reported earnings per share (EPS) of ($1.99). Learn more on analysts' earnings estimate vs. DWTX's actual earnings. How much profit does Dogwood Therapeutics generate each year? Dogwood Therapeutics (NASDAQ:DWTX) has a recorded net income of -$12.35 million. DWTX has generated -$18.78 earnings per share over the last four quarters. What is Dogwood Therapeutics' EPS forecast for next year? Dogwood Therapeutics' earnings are expected to grow from ($6.43) per share to ($4.57) per share in the next year. More Earnings Resources from MarketBeat Related Companies XLO Earnings Results CLNN Earnings Results MRSN Earnings Results SCYX Earnings Results RNXT Earnings Results ALXO Earnings Results OKUR Earnings Results ESLA Earnings Results CLSD Earnings Results BTAI Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:DWTX) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dogwood Therapeutics, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dogwood Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access